Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti Obesity Drugs. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110156608B reveals a novel catalytic route for p-chlorophenethylamine, offering safer processing and high purity for reliable pharmaceutical intermediate suppliers.
Patent CN101066924B reveals a streamlined chemical synthesis for Orlistat intermediates, offering high purity and scalable production for pharmaceutical manufacturers.
Patent CN106631823B details a safe, cost-effective synthesis of lorcaserin intermediates using sodium borohydride reduction, eliminating toxic borane and expensive reagents.